BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit July 17, 2020
Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites July 13, 2020
ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 July 8, 2020
BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering June 24, 2020
